Enhancing Health Care Value


Enhancing Health Care Value Through Data, Measurement and Evaluation of Services and Procedures


Wednesday, Nov. 3, 2021
1:00 - 3:00 p.m. ET



As Americans grapple with the enormous strain of the COVID-19 pandemic on humanity and the health system, there is a clear need to adapt the health system to more efficiently address the needs of patients. Each year billions of dollars are misplaced and wasted in the system due, in part, to a lack of understanding of the value we get for money. 

Evidence-based tools can help make sure money goes where it’s needed most. For decades, the field of health economics and outcomes research has designed and deployed methods to conduct clinical and economic evaluation of health interventions. These ever-evolving tools serve as an important foundation to assess value and efficiency across the health care system.  

But today, there is a large imbalance in how these methods are applied. The majority focus on medicines, even though prescription drugs make up less than 15% of health care spending. Value evidence must be applied more proportionately to other parts of the health system to meaningfully lower health spending, and to do so we must acknowledge and address key barriers to more holistic evidence generation. In doing so, we can learn lessons from decades of robust generation of value evidence for medicines.

All parts of the system should be accountable for making health care affordable and high value. We solicited thought leaders to tackle barriers and provide an agenda to inform more robust evidence generation on effectiveness and value of health care services. The experts authored briefs on different topics that Health Affairs is publishing in a series of upcoming blogs through November 2021. The RC-HCVA will also host a webinar, facilitated by Dr. Mark Fendrick, in which the panel of researchers will share their findings and insights into these topics.1 There will be an opportunity for questions and answers.


1:00 – 1:05 pm Welcome and Housing Keeping (George Miller, Co-Director of RC-HCVA)
1:05 – 1:15 pm Mark Fendrick (Co-Director of RC-HCVA and Facilitator – Introduction of today’s speakers)
1:15 – 1:30 pm

Value Defects in the Health Services Sector

  • William PadulaPhD: Assistant Professor, Department of Pharmaceutical and Health Economics, USC School of Pharmacy
  • Peter Pronovost, MD, PhD: University Hospitals Cleveland Medical Center
1:30 – 1:45 pm

Challenges and Barriers to Measuring Effectiveness of Health Service Interventions

  • R. Brett McQueen, PhD: pValue, Colorado University
1:45 – 2:00 pm

Challenges and Barriers to Measuring Cost of Health Service Interventions

  • Christopher WhaleyPhD:  RAND
2:00 – 2:15 pm

Why Are There So Few Value Assessments on Health Services and Procedures and What Should Be Done?

  • Peter NeumannPhD:  CEVA, Tufts Medical Center
  • Daniel OllendorfPhD: CEVA, Tufts Medical Center
2:15 – 2:30 pm

Emerging Health Technology Assessment Methods and Evidence Generation on Patient-Driven Values in Healthcare Services

  • Susan dosReis, PhD: PAVE, University of Maryland
  • Julia Slejko, PhD: PAVE, University of Maryland
2:30 – 2:45 pm

A Blueprint to Advance Patient-Centered Core Impact Sets (PC-CIS)

  • Eleanor M. Perfetto1,2Elisabeth Oehrlein1T. Rose Love2Silke Schoch1Jennifer Bright3Annie Kennedy4, and Suz Schrandt5
    • 1. National Health Council, Washington, DC
    • 2. University of Maryland, Baltimore, MD
    • 3. Innovation and Value Initiative, Washington, DC
    • 4. Everylife Foundation for Rare Diseases, Washington, DC
    • 5. Exppect, Washington, DC
3:00 pm Leveraging Community Benefit to Increase the Value of Health Care
  • Michael Rozier, PhD:  St. Louis University
  • Kimberly Enard, PhD: St. Louis University

1. The Research Consortium for Health Care Value Assessment (RC-HCVA) established the research Grant-Making Center in 2020 with support from the Pharmaceutical Research Manufacturers of America (PhRMA).